Hotermans, : rechercher sur Z-Library

Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Campagne de collecte 15 septembre 2024 – 1 octobre 2024

Z-Library est une des plus grandes bibliothèques en ligne dans le monde, avec le stockage de plus de 17,000,000 livres et plus de 84,837,000 articles. Nous encourageons l'accès libre de chacun à la littérature. Aujourd'hui (15 septembre 2024) nous faisons un appel de fonds à tous ceux qui veulent contribuer encore plus au soutien et au développement de notre projet.

Les téléchargements SANS LIMITE sont aussi (au cours de 31 jours après la date de don) disponibles pour TOUS les utilisateurs qui soient en mesure de soutenir le projet pendant la période de collecte de fonds jusqu'au 1 octobre 2024.

C'est quoi, la collecte de fonds?En savoir plus

Livres
Articles (29)
Les plus populaires
Liste
- Liste
- Tableau

1

Population Dynamics of CD4+ T Cells Lacking Thy-1 in Murine Retrovirus-Induced Immunodeficiency Syndrome (MAIDS)

M. P. MOUTSCHEN, S. COLOMBI, M. DEPREZ, F. VAN WIJK, C. HOTERMANS, M.-T. MARTIN, R. GREIMERS, J. BONIVER

Journal:

Scandinavian Journal of Immunology

Année:

1994

Langue:

english

Fichier:

PDF, 3.33 MB

english, 1994

2

Repetitive transcranial magnetic stimulation over the primary motor cortex disrupts early boost but not delayed gains in performance in motor sequence learning

Christophe Hotermans, Philippe Peigneux, Alain Maertens De Noordhout, Gustave Moonen, Pierre Maquet

Journal:

European Journal of Neuroscience

Année:

2008

Langue:

english

Fichier:

PDF, 400 KB

english, 2008

3

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Bloomgren, Gary, Richman, Sandra, Hotermans, Christophe, Subramanyam, Meena, Goelz, Susan, Natarajan, Amy, Lee, Sophia, Plavina, Tatiana, Scanlon, James V., Sandrock, Alfred, Bozic, Carmen

Journal:

New England Journal of Medicine

Année:

2012

Langue:

english

Fichier:

PDF, 567 KB

english, 2012

4

Somatosensory evoked potentials in lumbosacral disk disease: Diagnosis and prognosis interest in the follow-up of 120 operated cases

D. Debatisse, P. Desfontaines, J.M. Guerit, D. Maassen, D. Raket, J.M. Hotermans, I. Selak

Journal:

Electroencephalography and Clinical Neurophysiology

Année:

1993

Langue:

english

Fichier:

PDF, 198 KB

english, 1993

5

P314 Electrophysiological assessment of normal pressure hydrocephalus (NPH) before and after CSF drainage

I. Hansen, D. Debatisse, C. Witdoeckt, S. Bolyn, D. Raket, J.M. Hotermans, J.M. Guérit

Journal:

Electroencephalography and Clinical Neurophysiology

Année:

1996

Langue:

english

Fichier:

PDF, 141 KB

english, 1996

6

P-14 Early P300 and late P300 in 415 treated patients suffering from a depressive syndrome

D. Debatisse, N. Lesnicki, C. Witdoeckt, S. Bolyn, I. Hansen, D. Maassen, D. Rakett, B. Pirotte, M. Joset, M. Castermans, F. Dewispelaere, J.M. Guerit, J.M. Hotermans, F. Bartholome, M. Kruger, P. Des

Journal:

European Neuropsychopharmacology

Année:

1996

Langue:

english

Fichier:

PDF, 145 KB

english, 1996

7

P-15 Ambulatory eeg and sleep study in 194 treated depressed patients

N. Lesnicki, A. Boxus, C. Witdoeckt, S. Bolyn, I. Hansen, D. Massen, D. Raket, B. Pirotte, M. Joset, M. Casterman, F. Dewispelaere, J.M. Guerit, J.M. Hotermans, F. Bartholome, J.M. Kruger, P. Desfonta

Journal:

European Neuropsychopharmacology

Année:

1996

Langue:

english

Fichier:

PDF, 145 KB

english, 1996

8

Gastrointestinal tolerability events in relapsing–/INS;remitting multiple sclerosis patients treated with BG-12 (dimethyl fumarate): Integrated analysis of DEFINE and CONFIRM

Havrdova, E., Phillips, J.T., Selmaj, K., Gold, R., Fox, R.J., Giovannoni, G., Pace, A., Novas, M., Kurukulasuriya, N.C., Hotermans, C., Meltzer, L., Dawson, K.T.

Journal:

Journal of the Neurological Sciences

Année:

2013

Langue:

english

Fichier:

PDF, 84 KB

english, 2013

9

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

Butzkueven, H., Kappos, L., Pellegrini, F., Trojano, M., Wiendl, H., Patel, R. N., Zhang, A., Hotermans, C., Belachew, S.

Journal:

Journal of Neurology Neurosurgery & Psychiatry

Année:

2014

Langue:

english

Fichier:

PDF, 1.16 MB

english, 2014

10

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM

Voloshyna, N., Havrdová, E., Hutchinson, M., Nehrych, T., You, X., Belachew, S., Hotermans, C., Paes, D.

Journal:

European Journal of Neurology

Année:

2015

Langue:

english

Fichier:

PDF, 306 KB

english, 2015

11

Early boost and slow consolidation in motor skill learning

Hotermans, C., Peigneux, P., Maertens de Noordhout, A., Moonen, G., Maquet, P.

Journal:

Learning & Memory

Année:

2006

Langue:

english

Fichier:

PDF, 375 KB

english, 2006

12

Comparison of the Timed 25-Foot and the 100-Meter Walk as Performance Measures in Multiple Sclerosis

Phan-Ba, R., Pace, A., Calay, P., Grodent, P., Douchamps, F., Hyde, R., Hotermans, C., Delvaux, V., Hansen, I., Moonen, G., Belachew, S.

Journal:

Neurorehabilitation & Neural Repair

Année:

2011

Langue:

english

Fichier:

PDF, 883 KB

english, 2011

13

Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy

Hotermans, C., Belachew, S., Moonen, G., Delwaide, J.

Journal:

Multiple Sclerosis Journal

Année:

2009

Langue:

english

Fichier:

PDF, 69 KB

english, 2009

14

Therapeutic Use of High-Frequency Repetitive Transcranial Magnetic Stimulation in Stroke

Hotermans, C., Peigneux, P., Moonen, G., Maertens de Noordhout, A., Maquet, P.

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 283 KB

english, 2007

15

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Bloomgren, Gary, Richman, Sandra, Hotermans, Christophe, Subramanyan, Meena, Goelz, Susan, Natarajam, Amy, Lee, Sophia, Plavina, Tatiana, Scanlon, James V., Sandrock, Alfred, Bozic, Carmen

Journal:

Survey of Anesthesiology

Année:

2012

Langue:

english

Fichier:

PDF, 222 KB

english, 2012

16

Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis

Kappos, L., Giovannoni, G., Gold, R., Phillips, J. T., Arnold, D. L., Hotermans, C., Zhang, A., Viglietta, V., Fox, R. J.

Journal:

European Journal of Neurology

Année:

2015

Langue:

english

Fichier:

PDF, 375 KB

english, 2015

17

A Case of Tracheal Fibrolipoma

Baharloo, F., Corhay, J.L., Hotermans, G., Bury, Th., Grand, L., Radermecker, M.

Journal:

Acta Clinica Belgica

Année:

1994

Langue:

english

Fichier:

PDF, 1.86 MB

english, 1994

18

Effect of Histamine on Tumor Necrosis Factor Production by Human Monocytes

Hotermans, G., Bury, T., Radermecker, M.F.

Journal:

International Archives of Allergy and Immunology

Année:

1991

Langue:

english

Fichier:

PDF, 608 KB

english, 1991

19

Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)

Cohan, Stanley L., Moses, Harold, Calkwood, Jonathan, Tornatore, Carlo, LaGanke, Chris, Smoot, Kyle E., Meka, Venkata, Okwuokenye, Macaulay, Hotermans, Christophe, Mendoza, Jason P., Mann, Monica K.,

Journal:

Multiple Sclerosis and Related Disorders

Année:

2018

Langue:

english

Fichier:

PDF, 764 KB

english, 2018

20

071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch ® prescribing program

Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan, Goldberg, Judith D, Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Yu, Bei, Ren, Zheng, Hotermans, Christophe,

Journal:

Journal of Neurology Neurosurgery & Psychiatry

Année:

2018

Langue:

english

Fichier:

PDF, 47 KB

english, 2018

21

Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

Gudesblatt, Mark, Wisseman, Karl, Zarif, Myassar, Bumstead, Barbara, Fafard, Lori, Wilken, Jeffrey, Blitz, Karen, Buhse, Marijean, Santra, Sourav, Hotermans, Christophe, Lee, Lily

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 769 KB

english, 2018

22

Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

Gudesblatt, Mark, Wissemann, Karl, Zarif, Myassar, Bumstead, Barbara, Fafard, Lori, Wilken, Jeffrey, Blitz, Karen, Buhse, Marijean, Santra, Sourav, Hotermans, Christophe, Lee, Lily

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 509 KB

english, 2018

23

Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program

Zhovtis, Ryerson Lana, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan, Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Yu, Bei, Ren, Zheng, Hotermans, Christophe,

Journal:

Revue Neurologique

Année:

2019

Langue:

english

Fichier:

PDF, 107 KB

english, 2019

24

Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program

Zhovtis, Ryerson Lana, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan, Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Yu, Bei, Ren, Zheng, Hotermans, Christophe,

Journal:

Revue Neurologique

Année:

2019

Fichier:

PDF, 107 KB

2019

25

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE

Perumal, Jai, Fox, Robert J., Balabanov, Roumen, Balcer, Laura J., Galetta, Steven, Makh, Shavy, Santra, Sourav, Hotermans, Christophe, Lee, Lily

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 1024 KB

english, 2019

26

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE

Perumal, Jai, Fox, Robert J., Balabanov, Roumen, Balcer, Laura J., Galetta, Steven, Makh, Shavy, Santra, Sourav, Hotermans, Christophe, Lee, Lily

Journal:

Année:

2019

Fichier:

PDF, 1024 KB

2019

27

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan R., Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Kasliwal, Rachna, Ren, Zheng, Hotermans,

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 840 KB

english, 2019

28

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan R., Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Kasliwal, Rachna, Ren, Zheng, Hotermans,

Journal:

Année:

2019

Fichier:

PDF, 840 KB

2019

29

Ãvaluation des valeurs de lâindex des anticorps antiâJCV chez des patients atteints de SEP traitÃ©s par natalizumab avec une extension de lâintervalle de dose par rapport Ã lâintervalle de dose standardÂ : une analyse de la base de donnÃ©es TOUCHÂ®

Foley, John, Zhovtis, Ryerson Lana, Chang, Ih, IlyaÂ Kister,, Cutter, Gary, Metzger, Ryan, Riddle, Evan, Ren, Zheng, Hotermans, Christophe, Mason, Louise, Ho, Pei-Ran, Campbell, Nolan

Journal:

Revue Neurologique

Année:

2020

Fichier:

PDF, 258 KB

2020